首页 | 官方网站   微博 | 高级检索  
     

免疫检查点抑制剂在晚期黑色素瘤应用中的免疫相关不良反应研究进展
引用本文:席加喜,张华君,苏恒海,莫倩,谌赟.免疫检查点抑制剂在晚期黑色素瘤应用中的免疫相关不良反应研究进展[J].肿瘤药学,2023,13(1):23-28.
作者姓名:席加喜  张华君  苏恒海  莫倩  谌赟
作者单位:1.广西壮族自治区人民医院 药学部,广西 南宁,530021;2.湖南省肿瘤医院/中南大学湘雅医学院附属肿瘤医院 药学部,湖南 长沙,410000
摘    要:免疫检查点抑制剂自出现以来,在临床上应用越来越广泛,但随着适用范围的扩大和使用时间的延长,其导致的免疫相关不良反应也越来越突出。严重的免疫相关不良反应可以影响患者的生存质量,因此,临床工作中必须对这些不良反应予以重视。本文综合了不同的临床试验结果,对免疫检查点抑制剂在治疗晚期黑色素瘤中发生的免疫相关不良反应进行了总结。

关 键 词:免疫检查点抑制剂  晚期黑色素瘤  免疫相关不良反应

Research progress on immune-related adverse effects of immune checkpoint inhibitors in advanced melanoma
XI Jiaxi,ZHANG Huajun,SU Henghai,MO Qian,CHEN Yun.Research progress on immune-related adverse effects of immune checkpoint inhibitors in advanced melanoma[J].Anti-Tumor Pharmacy,2023,13(1):23-28.
Authors:XI Jiaxi  ZHANG Huajun  SU Henghai  MO Qian  CHEN Yun
Affiliation:1.Department of Pharmacy, the People''s Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, Guangxi,China;2.Department of Pharmacy, Hunan Cancer Hospital / the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China
Abstract:Immune checkpoint inhibitors have been used more and more widely in clinical practice since their emergence. However, with the expansion of their application scope and the extension of their using time, more and more immune-related adverse reactions caused by them are reported. Serious immune-related adverse reactions can affect the quality of life of patients, so it is necessary to pay attention to these adverse reactions in clinical work. This review summarized the immune-related adverse reactions of immune checkpoint inhibitors in the treatment of advanced melanoma by combining the results of different clinical trials.
Keywords:Immune checkpoint inhibitors  Advanced melanoma  Immune-related adverse reactions
点击此处可从《肿瘤药学》浏览原始摘要信息
点击此处可从《肿瘤药学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号